Investing.com - Elevance Health (NYSE: ELV) reported first quarter EPS of $10.64, $0.16 better than the analyst estimate of $10.48. Revenue for the quarter came in at $42.3B versus the consensus estimate of $42.47B.
Guidance
Elevance Health sees FY 2024 EPS of $37.20 versus the analyst consensus of $37.15.
Elevance Health's stock price closed at $508.97. It is up 9.55% in the last 3 months and up 11.29% in the last 12 months.
Elevance Health saw 8 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Elevance Health's stock price’s past reactions to earnings here.
According to InvestingPro, Elevance Health's Financial Health score is "great performance".
Check out Elevance Health's recent earnings performance, and Elevance Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar